Oral Administration of the Immunodominant B-chain of Insulin Reduces Diabetes in a Co-transfer Model of Diabetes in the NOD Mouse and is Associated with a Switch from Th1 to Th2 Cytokines
- 1 August 1997
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 10 (4) , 339-346
- https://doi.org/10.1006/jaut.1997.0148
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- T Helper Cell Subsets in Insulin-Dependent DiabetesScience, 1995
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Recombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic MouseClinical Immunology and Immunopathology, 1994
- Altered Cytokine Activity in Adjuvant Inhibition of Autoimmune DiabetesJournal of Autoimmunity, 1993
- Islet cell antigens in insulin-dependent diabetes: Pandora's box revisitedImmunology Today, 1992
- Antigen-driven bystander suppression after oral administration of antigens.The Journal of Experimental Medicine, 1991
- Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chainNature, 1990
- Type-I Diabetes: A Chronic Autoimmune Disease of Human, Mouse, and RatAnnual Review of Immunology, 1990
- The regulation of immune responses to dietary protein antigensImmunology Today, 1987